Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1
- 12 April 2002
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1587 (2-3), 318-325
- https://doi.org/10.1016/s0925-4439(02)00095-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- STI571 Revolution: Can the Newer Targeted Drugs Measure Up?JNCI Journal of the National Cancer Institute, 2001
- Chronic myelogenous leukemiaCurrent Opinion in Oncology, 2001
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- Gene therapy for prostate cancerSeminars in Cancer Biology, 1997
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal Of Cancer, 1996
- Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cellsFEBS Letters, 1996
- Comparative analysis of somatostatin analog peptides by capillary electrophoresis and micellar elektrokinetic chromatographyElectrophoresis, 1996
- Calcein accumulation as a fluorometric functional assay of the multidrug transporterBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Multidrug resistance in human cancerCritical Reviews in Oncology/Hematology, 1992